← Back to Clinical Trials
Recruiting NCT06956755
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Trial Parameters
Condition Myelodysplastic Syndromes
Sponsor Groupe Francophone des Myelodysplasies
Study Type OBSERVATIONAL
Phase N/A
Enrollment 6,990
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2003-07-07
Completion 2030-01-05
All Conditions
Brief Summary
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia
Eligibility Criteria
Inclusion Criteria: * Male or female * Age \> 18 years * Patients with myelodysplastic syndrome and therapy-related acute myeloid leukemia * Able and willing to provide written informed consent Exclusion Criteria: * Age \<18 years * Patient is unwilling or unable to give consent
Related Trials
NCT05875805
A Telehealth Advance Care Planning Intervention
View Trial →
NCT06956755
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
View Trial →
NCT07238686
Venetoclax-containing Therapy Combined With Microtransplant for Intermediate-risk and Higher MDS
View Trial →